Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Lanraplenib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kronos Begins Dosing in PIb/II Trial of Lanraplenib with Gilteritinib
    Kronos Begins Dosing in PIb/II Trial of Lanraplenib with Gilteritinib

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2502156/0/en/Kronos-Bio-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Lanraplenib-in-Combination-with-Gilteritinib-in-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    Kronos Bio's SYK Inhibitors Entospletinib and Lanraplenib at EHA 2022
    Kronos Bio's SYK Inhibitors Entospletinib and Lanraplenib at EHA 2022

    12 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/12/2442168/0/en/Kronos-Bio-s-Investigational-SYK-Inhibitors-Entospletinib-and-Lanraplenib-to-be-Featured-in-Four-Poster-Presentations-at-EHA2022-Congress.html

    GLOBENEWSWIRE
    12 May 2022
    Share Share